To provide that a portion of the performance awards of each employee of the Center for Drug Evaluation and Research, the Center for Devices and Radiological Health, and the Center for Biologics Evaluation and Research be connected to an evaluation of the employee's contribution to goals under the user fee agreements.
What it does: Adds SEC. 11__. PERFORMANCE AWARDS at the end of title XI
Sen. Tom Coburn (R-OK)What it changes
1 change to S. 3187 · shown in the bill's text
Adds SEC. 11__. PERFORMANCE AWARDS at the end of title XI
Adds a sectionIn S. 3187 · Placed on Calendar Senate
"(b) Financial Interest.--In this section, the term 'financial interest' means a financial interest under section 208(a) of title 18, United States Code.".
Inserted: SEC. 11__. PERFORMANCE AWARDS.
Inserted: (a) In General.--Not later than 1 year after the date of enactment of this Act, the Secretary of Health and Human Services (referred to in this section as the "Secretary") shall establish a system by which a portion of the performance awards of each employee described in subsection (b) shall be connected to the evaluation of the employee's contribution, in the discretion of the Secretary, to the goals under the user fee agreements described in section 101(b), 201(b), 301(b), or 401(b), as appropriate.
Inserted: (b) Employees Described.--
Inserted: (1) In general.--Subsection (a) shall apply only to employees who--
Inserted: (A) are employed by the Center for Drug Evaluation and Research, the Center for Devices and Radiological Health, or the Center for Biologics Evaluation and Research; and
Inserted: (B) are involved in the review of drugs, devices, or biological products.
Inserted: (2) Commissioned corps.--For purposes of this section, the term "employee" includes members of the Public Health Service Commissioned Corps.
Inserted: (c) Effect on Award.--The degree to which the performance award of an employee is affected by the evaluation of the employee's contribution to the goals under the user fee agreements, as described in subsection (a), shall be proportional to the extent to which the employee is involved in the review of drugs, devices, or biological products.
Inserted: (d) Report.--The Secretary shall issue an annual report detailing how many employees were involved in meeting the goals under the user fee agreements described in section 101(b), 201(b), 301(b), and 401(b), and the manner of the involvement of such employees.
Original wording
At the end of title XI, add the following:
Read automatically from the Congressional Record. Check the original before relying on it.
As printed
SA 2132. Mr. COBURN (for himself and Mr. Burr) submitted an amendment intended to be proposed by him to the bill S. 3187, to amend the Federal Food, Drug, and Cosmetic Act to revise and extend the user-fee programs for prescription drugs and medical devices, to establish user-fee programs for generic drugs and biosimilars, and for other purposes; which was ordered to lie on the table; as follows:
At the end of title XI, add the following:
SEC. 11__. PERFORMANCE AWARDS.
(a) In General.--Not later than 1 year after the date of enactment of this Act, the Secretary of Health and Human Services (referred to in this section as the “Secretary”) shall establish a system by which a portion of the performance awards of each employee described in subsection (b) shall be connected to the evaluation of the employee's contribution, in the discretion of the Secretary, to the goals under the user fee agreements described in section 101(b), 201(b), 301(b), or 401(b), as appropriate.
(b) Employees Described.--
(1) In general.--Subsection (a) shall apply only to employees who--
(A) are employed by the Center for Drug Evaluation and Research, the Center for Devices and Radiological Health, or the Center for Biologics Evaluation and Research; and
(B) are involved in the review of drugs, devices, or biological products.
(2) Commissioned corps.--For purposes of this section, the term “employee” includes members of the Public Health Service Commissioned Corps.
(c) Effect on Award.--The degree to which the performance award of an employee is affected by the evaluation of the employee's contribution to the goals under the user fee agreements, as described in subsection (a), shall be proportional to the extent to which the employee is involved in the review of drugs, devices, or biological products.
(d) Report.--The Secretary shall issue an annual report detailing how many employees were involved in meeting the goals under the user fee agreements described in section 101(b), 201(b), 301(b), and 401(b), and the manner of the involvement of such employees.
Legislative Activity
Stay on top of the latest movement without scrolling through every action
Considered by Senate. (consideration: CR S3536)
May 24, 2012
View full timeline
Considered by Senate. (consideration: CR S3536)
May 24, 2012
Proposed amendment SA 2132 withdrawn in Senate. (consideration: CR S3547)
May 24, 2012
Senate amendment proposed (on the floor): Amendment SA 2132 proposed by Senator Coburn.(consideration: CR S3489-3490; text: CR S3489-3490)
May 23, 2012
Amendment SA 2132 proposed by Senator Coburn. (consideration: CR S3489-3490; text: CR S3489-3490) To provide that a portion of the performance awards of each employee of the Center for Drug Evaluation and Research, the Center for Devices and Radiological Health, and the Center for Biologics Evaluation and Research be connected to an evaluation of the employee's contribution to goals under the user fee agreements.
May 23, 2012
Senate amendment submitted
May 22, 2012